Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area
Hematology Reports · 2009
DOI: 10.4081/hr.2009.e2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology Reports, 2009. Verfasst von Hans E. Johnsen und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Johnsen, H. E., Björkstrand, B., Klausen, T. W., Remes, K., Gruber, A., Knudsen, L. M., Bergmann, O. J., & Lenhoff, S. (2009). Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area. Hematology Reports. https://doi.org/10.4081/hr.2009.e2
Vancouver
Johnsen HE, Björkstrand B, Klausen TW, Remes K, Gruber A, Knudsen LM, et al. Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area. Hematology Reports. 2009. doi:10.4081/hr.2009.e2
BibTeX
@article{Johnsen2009,
author = {Johnsen, Hans E. and Björkstrand, Bo and Klausen, Tobias W. and Remes, Kari and Gruber, Astrid and Knudsen, Lene M. and Bergmann, Olav J. and Lenhoff, Stig},
title = {Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area},
journal = {Hematology Reports},
year = {2009},
doi = {10.4081/hr.2009.e2}
}
EUVIMED